| 22900 | NARCAG | Narcolepsy Associated Antigen (NARC) | Narcolepsy Associated Ag, B | | | 26322 | NASCOV | Nasal COVID 19 Nucleic Acid Test (NAT) PCR | COVID 19 PCR, SARS-CoV-2, Coronavirus | | | 23294 | NASHSO | NASH FibroSURE (550140) | Fatty Liver Disease, NAFLD, Nonalcoholic Fatty Liver Disease, Noninvasive Liver Biopsy, Steatohepatitis | a2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, y-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol, triglycerides, and fasting glucose | | 25063 | NK | Natural Killer (CD16, CD56, CD57) Profile | Flow Cytometry | | | 23232 | | Natural Killer Cells | Flow Cytometry, Killer Cells | | | 26464 | MGRNASO | Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies (MGRNA) | Neisseria gonorrhoeae RNA amplification Gonorrhoeae Gonorrhea Neisseria gonorrhoeae RNA Probe | | | 22901 | GC-NAM | Neisseria Gonorrhoeae, Nucleic Acid Method (NAM) | Neisseria gonorrhoea, Gonorrhea, GC | | | 25223 | NEO | Neonatal Screen (281) | PKU-Newborn Screening, CAH Trypsinogen Screen, Newborn Screening | | | 24742 | BBNBSCN | Neonate Transfusion | Neonate type and screen, Newborn type and screen, Newborn transfusion, Quad pack, BBNBSCN, Newborn Type & AbScn & DAT | ABO/RH, DAT, ABSC, may include Weak D. | | 25597 | NMOFSSO | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum (NMOFS) | AQP, AQP4, Aquaporin, Devic's Antibody, NMO (Neruomyelitis Optica), NMO-IgG, Optic Neuritis Antibody, Transverse Myelitis Antibody, Vision Loss Antibody33 | When the results of this assay require further evaluation, NMOTS/Neuromyelitis Optica (NMO)/Auaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Titer Assay, Serum will be performed at an additional charge. | | 22904 | NSESO | Neuron-Specific Enolase (NSE) | NSE Enolase | | | 26294 | NONCPSO | Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor (NONCP) | ATRX
BRAF
Brain tumor
Central nervous system (CNS) cancers
EGFR
H3F3A
HIST1H3B
HIST1H3C
IDH1
IDH2
Next Gen Sequencing Test
NGS
Oncology panel
RELA
SMARCA4
SMARB1
TERT NeuroOnc Exp GenPa Tum (NONCP) TI NONCPSO | | | 26017 | NGSAMSO | Next-Gen Sequencing, Acute Myeloid Leukemia(NGAML) | FLT3, NPM1, CEPBA, IDH1, IDH2, KRAS, NRAS, TP53, Next generation sequencing of leukemia, Next Gen Sequencing Test, NGS for acute myeloid leukemia evaluation, NGS hematologic malignancies, Somatic mutation detection by next generation sequencing (NGS), hematologic, DNMT3A, KIT, RUNX1, NGAML | This test includes next-generation sequencing to evaluate for the following 11 genes: CEBPA, DNMT3A, FLT3, IDH1, IDH2, KIT, KRAS, NPM1, NRAS, RUNX1, and TP53. | | 26018 | NGSHMSO | Next-Gen Sequencing, Hematologic Neoplasms (NGSHM) | NGS hematologic malignancies, NGS cancer panel, hematologic, Somatic mutation detection by next generation sequencing (NGS), hematologic, Next gen sequencing of leukemia (AML) and myelodysplasia (MDS), NGS for myeloid neoplasm evaluation (MPN), Next Gen Sequencing Test, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TERT, TET2, TP53, U2AF1, WT1, ZRSR2, ANKRD26, DDX41, ELANE, ETNK1, KDM6A, RAD21, SH2B3, SRP72, SMC3, STAG2 | This test includes next-generation sequencing to evaluate for the following 42 genes and select intronic regions: ANKRD26, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DDX41, DNMT3A,ELANE, ETNK1, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KDM6A, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RAD21, RUNX1, SETBP1, SH2B3, SF3B1, SRP72, SMC3, SRSF2, STAG2,TERT, TET2, TP53, U2AF1, WT1, and ZRSR2. | | 26465 | NGAMTSO | Next-Generation Sequencing Acute Myeloid Leukemia, Therapeutic Gene Mutation Panel (FLT3, IDH1, IDH2, TP53), Varies (NGAMT) | NGS Acute Myeloid Leukemia, Therapeutic Gene Mutation Pnl (FLT3, IDH1, IDH2, TP53), Varies (NGAMT) FLT3 IDH1 IDH2 Next gen sequencing of leukemia (AML) Next Gen Sequencing Test NGS cancer panel, hematologic NGS hematologic malignancies Somatic mutation detection by next generation sequencing (NGS), hematologic TP53 Enasidenib therapy Midostaurin therapy | This test includes next-generation sequencing to evaluate for the following 4 genes: FLT3, IDH1, IDH2, and TP53. | | 25045 | NICTS | Nicotine and Metabolites, Serum | Cotinine, Nicotine Metabolite, 3-OH-cotinine, trans-3-hydroxycotinine, trans-3-OH-cotinine | | | 26128 | NICOSSO | Nicotine and Metabolites, Serum (NICOS) | Cotinine, Tobacco Alkaloids | Nicotine, Cotinine | | 26296 | CO-NICT | Nicotine and Metabolites, Urine Confirm only by LCMSMS | | This is a quantitative urine test utilizing Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS) using Multiple Reaction Monitoring to determine presence and concentration of nicotine and cotinine. | | 25594 | NMDARSO | N-methyl-D-Aspartate Receptor Antibody, IgG, CSF with Reflex to Titer (2005164) | anti-GluN1, Anti-NMDA CSF, anti-NR1, Glutamate Receptor Antibodies, N-Methyl D-Aspartate Ab CSF, NMDA R, NMDA Receptor Ab CSF | | | 26197 | NMH24SO | N-Methylhistamine, 24 hr U (NMH24) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine N-Methylhist. 24 Hr U (NMH24) N-Methylhistamine, 24 Hour, Urine 24 NM24SO | N-Methylhistamine, 24 Hr, U Creatinine, 24 Hr, U | | 26198 | NMHRSO | N-Methylhistamine, Urine (NMHR) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine NMHR NMH N-Methylhistamine N-Methylhistamine, Random, Urine N-Methylhist. Rand, U (NMHR) U NMHRSO | N-Methylhistamine, Random Creatinine, Random, U | | 24994 | NMOESO | NMO/AQP4-IgG Cell Binding Assay (NMOCS) | AQP, AQP4, Aquaporin, Devic's Antibody, NMO (Neuromyelitis Optica), NMO-IgG, Optic Neuritis Antibody, Transverse Myelitis Antibody, Vision Loss Antibody | | | 23145 | NMRLISO | NMR Lipoprotein Quant 123638 | NMR, Small dense LDL, HDL-C | Color graphical report; historical reporting (LDL-P, LDL-C); insulin resistance and diabetes risk markers (large VLDL-P, small LDL-P, large HDL-P, VLDL size, LDL size, HDL size); insulin-resistance score; lipoprotein particle number (LDL-P); particle concentration and size (total HDL-P, small LDL-P, LDL size); standard lipid panel (total cholesterol, calculated LDL cholesterol, HDL cholesterol, triglycerides). | | 26133 | LNOROSO | Norovirus PCR, Molecular Detection, Feces | Norwalk virus Norovirus PCR, Feces ST LNOROSO | | | 22906 | NORTSO | Nortriptyline (NOTRP) | Aventyl (Nortriptyline), Serum, Nortriptyline, Serum, Pamelor (Nortriptyline), Serum, Sensoval, Aventyl, Pamelor, Norpress, Allegron, and Nortrilen (Nortriptyline), TCA (Tricyclic Antidepressants), Tricyclic Antidepressants (TCA) | | | 25075 | NPMCBSO | NPM1 Mutation with CEBPA Analysis if Needed (4637) | Ref Lab Code: 4637 | | | 23225 | NTXBSO | N-Telopeptide X-Link, Serum (SNTX) | Collagen Crosslinks, Crosslinked N-telopeptide of Type I Collagen (NTX), Serum, N-Telopeptide, Serum, NTX, Osteomark, Osteoporosis | N-Terminal Telolpeptide | | 22907 | NTXSO | NTX-Telopeptide, Urine (NTXPR) | Collagen Crosslinks
Crosslinked N-telopeptide of Type I Collagen (NTX), Urine
N-Telopeptide, Urine
NTX Creatinine
Osteomark
Osteoporosis NTXPR U NTXSO | |
|